[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336568-105":59,"doc-detail-336568-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","carbon-nanomaterials-as-carriers-for-the-anti-cancer-drug-doxorubicin-a-review-on-theoretical-and-experimental-studies","Carbon nanomaterials as carriers for the anti-cancer drug doxorubicin - a review on theoretical and experimental studies","","A review addresses the role of carbon-based nanomaterials as drug carriers for doxorubicin (DOX), an anthracycline used against multiple cancers. The article summarizes why DOX’s efficacy is limited by serious side effects, and how nanocarrier strategies—including graphene, graphene oxide, and carbon nanotubes—aim to enable more targeted delivery. It also consolidates theoretical and experimental findings on carrier fate after administration and the routes by which the body eliminates these nanomaterials, concluding with an assessment of associated toxicities.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/carbon-nanomaterials-as-carriers-for-the-anti-cancer-drug-doxorubicin-a-review-on-theoretical-and-experimental-studies/336568/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/carbon-nanomaterials-as-carriers-for-the-anti-cancer-drug-doxorubicin-a-review-on-theoretical-and-experimental-studies/336568.png","ImageObject",300,407,{"name":92,"@type":93},"Oliver","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is doxorubicin widely used, and what major drawbacks does it have?","Question",{"text":112,"@type":113},"Doxorubicin is an effective anthracycline anti-cancer drug used for many cancers. Its clinical use is constrained by significant side effects, including lethal cardiotoxicity and other toxicities that can impair quality of life.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What carbon-based nanomaterials are discussed as carriers for DOX?",{"text":117,"@type":113},"The review focuses on carbon-based materials such as graphene, graphene oxide, and carbon nanotubes. These materials are presented as carrier platforms for DOX delivery.",{"name":119,"@type":110,"acceptedAnswer":120},"What does the review cover regarding carrier fate after drug delivery?",{"text":121,"@type":113},"It consolidates information about how carriers behave after delivering DOX at the action site. It also describes different imaging techniques and the pathways through which the body eliminates these nanomaterials.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336568,1790751087,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":26,"preview_page_count":19,"preview_urls":145},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Nanoscale Advances  \n[rsc.li/nanoscale-advances](rsc.li/nanoscale-advances)  \nISSN 2516-0230  \nREVIEW ARTICLE  \nK. Gayathri and R. Vidya  \nCarbon nanomaterials as carriers for the anti-cancer drug doxorubicin: a review on theoretical and experimental studies  \nNanoscale Advances  \nREVIEW  \nCite this: Nanoscale Adv., 2024, 6, 3992  \nReceived 2nd April 2024  \nAccepted 26th April 2024 DOI: 10.1039/d4na00278d[rsc.li/nanoscale-advances](rsc.li/nanoscale-advances)  \nCarbon nanomaterials as carriers for the anticancer drug doxorubicin: a review on theoretical and experimental studies  \nK. Gayathri ab and R. Vidya  *ab  \nThe incidence of cancer is increasing worldwide in a life-threatening manner. In such a scenario, the development of anti-cancer drugs with minimal side eﬀects and eﬀective drug delivery systems is of paramount importance. Doxorubicin (DOX) is one of the powerful anti-cancer drugs from the chemical family anthracycline, which is used to treat a wide variety of cancers, including breast, prostate, ovarian, and hematological malignancies. However, DOX has been associated with many side eﬀects, including lethal cardiotoxicity, baldness, gastrointestinal disturbances and cognitive function impairment. Eventhough DOX is administered in liposomal formulations to reduce its toxicity and enhance its therapeutic proﬁle, the liposomal formulations themselves have certain therapeutic proﬁle limitations such as“palmar-plantar erythrodysesthesia (PPE)”, which shows severe swelling and redness in the skin, thus restricting the dosage and reducing patient compliance. In contemporary chemotherapy research, thereis a great interest in the utilization of nanomaterials for precise and targeted drug delivery applications, especially using carbon-based nanomaterials. This review provides a comprehensive overview of both experimental and theoretical scientiﬁc works, exploring diverse forms of carbon-based materials such as graphene, graphene oxide, and carbon nanotubes that function as carriers for DOX. In addition, thereview consolidates information on the fate of the carriers after the delivery of the payload at the site of action through diﬀerent imaging techniques and the various pathways through which the body eliminates these nanomaterials. In conclusion, the review presents a detailed overview of the toxicities associated with these carriers within the human body, contributing to the development of enhanced drug delivery systems.  \nIntroduction  \nIn recent years, anti-cancer drugs have been among the topselling drugs in the market, which indicates the severity of cancer on a global scale. Oncology drugs always have an increasing trends in drug approval.1 Among the 37 novel drugs that were approved by the Food and Drug Administration (FDA) in 2022, 10 are oncology drugs, accounting for 27% of the overall approval. Cancer is a group of more than hundreds of diseases in multi-cellular organisms and is characterized by the abnormal growth of cells due to the alteration or mutations in gene sequences leading to the dysregulation of cell death and proliferation, which ends up in the formation of a group of cells that can invade, metastasize distant organs and cause signi􀀁 -cant morbidity in the host. The metastatic potential, invasiveness, and morphology of the diﬀerent cancers are also diﬀerent,  \naCentre for Materials Informatics(C-mAIn), Sir. C.V. Raman Science Block, Anna University, Sardar Patel Road, Guindy, Chennai 600 025, India. E-mail: vidyar@ [annauniv.edu](annauniv.edu); [vidyapl.ravi@gmail.com](vidyapl.ravi@gmail.com)  \nbDepartment of Physics, Anna University, Sardar Patel Road, Guindy, Chennai 600 025, India  \nwhich makes the prognosis of the disease harder.2 The incidence of cancer cases around the world is increasing rapidly, especially in India. It is also predicted to increase from 1.46 million in 2022 to 1.57 million in 2025 . Among the diﬀerent types of cancers, breast, cervical, and ovarian cancers are the top three c","cbCaipr3tkn9BQHR","https://ap.wps.com/l/cbCaipr3tkn9BQHR","pdf",1369550,24,"English","# Introduction\n# Carbon nanomaterials as DOX carriers - review scope and rationale\n## DOX background, side effects, and need for improved delivery\n## Carbon-based carriers and targeted delivery concept\n# Mechanism and historical context of doxorubicin\n## Action in cancer cells\n## Development history and therapeutic use","[{\"question\":\"Why is doxorubicin widely used, and what major drawbacks does it have?\",\"answer\":\"Doxorubicin is an effective anthracycline anti-cancer drug used for many cancers. Its clinical use is constrained by significant side effects, including lethal cardiotoxicity and other toxicities that can impair quality of life.\"},{\"question\":\"What carbon-based nanomaterials are discussed as carriers for DOX?\",\"answer\":\"The review focuses on carbon-based materials such as graphene, graphene oxide, and carbon nanotubes. These materials are presented as carrier platforms for DOX delivery.\"},{\"question\":\"What does the review cover regarding carrier fate after drug delivery?\",\"answer\":\"It consolidates information about how carriers behave after delivering DOX at the action site. It also describes different imaging techniques and the pathways through which the body eliminates these nanomaterials.\"}]","Carbon nanomaterials as carriers for the anti-cancer drug doxorubicin - a review on theoretical and experimental studies | PDF",1790015654,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6997f0d6b1abe833c301dda16bd7b386.webp",983,1287,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c3d0f7c964ee615547b0a4dbd3babb11.webp",982,1286,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e8d8ecdc4d504cc03591a6f51a3d6309.webp",981,1284,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c8ac5082d64b032bcb3ca6648f210b1f.webp",980,1283]